Pharmacogenomics Market Use in Metabolic and Endocrine Drug Management

The Global Pharmacogenomics Market was valued at US$ 5.58 Billion in 2024 and is expected to grow at a CAGR of 10.6% from 2024 to 2034. In 2024, North America led the market, achieving over 48.5% share with a revenue of US$ 2.7 Billion. Click here for more information: https://market.us/report/pharmacogenomics-market/